Latest stories on GH
GH Maintained by BTIG -- Price Target Raised to $210
GuruFocus63 · neutralanalyst
BTIG raises Guardant Health stock price target on growth outlook
Investing.com Analyst Ratings64 · neutralanalyst
Guardant Health Price Target Raised To 210 From 195 At Btig
The Fly64 · neutralanalyst
Roth starts Guardant Health with Buy on ‘premium growth’
The Fly64 · neutralanalyst
Guardant Health initiated with a Buy at Roth Capital
The Fly63 · neutralanalyst
Guardant Health spotlights 25 ESMO 2026 abstracts as methylation-based ctDNA monitoring takes center stage
October 21, 2026
MarketChameleon58 · neutralproduct/pr
Guardant to present 25 abstracts on liquid biopsy research portfolio at ESMO
The Fly56 · neutralproduct/pr
Guardant Health Highlights Broad Liquid Biopsy Research Portfolio at ESMO Congress 2026
StockTitan58 · neutralproduct/pr
Guardant Health: Growth Remains Too Expensive, Reiterate Hold
Seeking Alpha44 · neutralanalyst
The AI Trade Just Moved Into Your Bloodstream, and 4 Healthcare Stocks Are Winning
MarketBeat64 · neutralgeneral
Guardant Health loses challenge regarding DNA sequencing patent
Seeking Alpha34 · bearishgeneral
TwinStrand Biosciences says US PTABL rejects Guardant challenge to patent
The Fly63 · neutralgeneral
Guardant presents data from role of blood-based testing in CRC screening
The Fly58 · neutralproduct/pr
Guardant Health Shield Blood Test Demonstrates Leading Screening Adherence and CRC Deaths Averted Compared to Stool-Based Tests
StockTitan64 · neutralproduct/pr
Liquid Biopsy Market Research to Reach USD 27.42 Billion by 2035 as Cancer Blood Tests, AI Diagnostics and Precision Oncology Advance
GlobeNewswire58 · neutralproduct/pr
Guardant Health price target raised to $200 from $185 at Morgan Stanley
The Fly64 · neutralanalyst
Guardant Health price target raised to $200 from $195 at BofA
The Fly63 · neutralanalyst
Guardant announces Europe approval of Guardnat360 CDx as Etcamaha companion
The Fly74 · bullishproduct/pr
Guardant Health to Report Third Quarter 2026 Financial Results on November 5, 2026
StockTitan50 · neutralearnings
Guardant Health price target raised to $220 from $200 at Barclays
The Fly61 · neutralanalyst
Nasdaq Breaks Out To New Highs; Shopify, Taiwan Semiconductor, Guardant Health In Focus
Investors.com63 · neutralgeneral
Guardant Health reports COSMOS study published in Cancer Research Communications
The Fly63 · neutralproduct/pr